Awareness and clinical impact of the revised FDA warning on menopausal hormone therapy among Latin American physicians. REDLINC XIV.

Blümel JE, Vallejo MS, Chedraui P, Salinas H, Aedo S, Schüle A, Ribeiro Valadares AL, Bencosme A, Escalante C, Salinas C, Rey C, Navarro-Despaigne DA, Rodríguez-Vidal D, Ojeda E, González E, Arteaga E, Ayala F, Morera F, Ayala G, Fernández G, Solis G, Gutiérrez-Crespo H, Izaguirre H, Garcia I, Moreno J, Matzumura-Kasano J, Tserotas K, Costa-Paiva L, Hernández LR, Basavilvazo MA, Martino M, López M, Aguirre MS, Rodrigues MAH, Aldrighi JM, Dextre M, Ñañez M, de Melo NR, Carpintero P, Barriga P, Machado RB

Open source

DOI
10.1097/gme.0000000000002893
Published
2026 Oct 6
Container
Menopause (New York, N.Y.)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/gme.0000000000002893,
  title = {Awareness and clinical impact of the revised FDA warning on menopausal hormone therapy among Latin American physicians. REDLINC XIV.},
  author = {Blümel JE and Vallejo MS and Chedraui P and Salinas H and Aedo S and Schüle A and Ribeiro Valadares AL and Bencosme A and Escalante C and Salinas C and Rey C and Navarro-Despaigne DA and Rodríguez-Vidal D and Ojeda E and González E and Arteaga E and Ayala F and Morera F and Ayala G and Fernández G and Solis G and Gutiérrez-Crespo H and Izaguirre H and Garcia I and Moreno J and Matzumura-Kasano J and Tserotas K and Costa-Paiva L and Hernández LR and Basavilvazo MA and Martino M and López M and Aguirre MS and Rodrigues MAH and Aldrighi JM and Dextre M and Ñañez M and de Melo NR and Carpintero P and Barriga P and Machado RB},
  year = {2026},
  journal = {Menopause (New York, N.Y.)},
  doi = {10.1097/gme.0000000000002893},
  url = {https://doi.org/10.1097/gme.0000000000002893}
}

RIS

TY  - JOUR
TI  - Awareness and clinical impact of the revised FDA warning on menopausal hormone therapy among Latin American physicians. REDLINC XIV.
AU  - Blümel JE
AU  - Vallejo MS
AU  - Chedraui P
AU  - Salinas H
AU  - Aedo S
AU  - Schüle A
AU  - Ribeiro Valadares AL
AU  - Bencosme A
AU  - Escalante C
AU  - Salinas C
AU  - Rey C
AU  - Navarro-Despaigne DA
AU  - Rodríguez-Vidal D
AU  - Ojeda E
AU  - González E
AU  - Arteaga E
AU  - Ayala F
AU  - Morera F
AU  - Ayala G
AU  - Fernández G
AU  - Solis G
AU  - Gutiérrez-Crespo H
AU  - Izaguirre H
AU  - Garcia I
AU  - Moreno J
AU  - Matzumura-Kasano J
AU  - Tserotas K
AU  - Costa-Paiva L
AU  - Hernández LR
AU  - Basavilvazo MA
AU  - Martino M
AU  - López M
AU  - Aguirre MS
AU  - Rodrigues MAH
AU  - Aldrighi JM
AU  - Dextre M
AU  - Ñañez M
AU  - de Melo NR
AU  - Carpintero P
AU  - Barriga P
AU  - Machado RB
PY  - 2026
JO  - Menopause (New York, N.Y.)
DO  - 10.1097/gme.0000000000002893
UR  - https://doi.org/10.1097/gme.0000000000002893
ER  -

APA

JE, B., MS, V., P, C., H, S., S, A., A, S., AL, R. V., A, B., C, E., C, S., C, R., DA, N., D, R., E, O., E, G., E, A., F, A., F, M., G, A., G, F., G, S., H, G., H, I., I, G., J, M., J, M., K, T., L, C., LR, H., MA, B., M, M., M, L., MS, A., MAH, R., JM, A., M, D., M, Ñ., NR, D. M., P, C., P, B., & RB, M. (2026). Awareness and clinical impact of the revised FDA warning on menopausal hormone therapy among Latin American physicians. REDLINC XIV.. Menopause (New York, N.Y.). https://doi.org/10.1097/gme.0000000000002893

Source records